Management and outcome of pregnancies with parvovirus B19 infection over seven years in a tertiary fetal medicine unit

Fetal Diagnosis and Therapy

Volumn 25, Issue 4, 2009, Pages 373-378

  Simms, R A ^a   Liebling, R E ^a   Patel, R R ^a   Denbow, M L ^a   Abdel Fattah, S A ^a   Soothill, P W ^b   Overton, T G ^a  

^a ST MICHAEL'S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Fetal anaemia; Fetal hydrops; Fetal thrombocytopenia; Intrauterine transfusion; Maternal serum alpha fetoprotein; Parvovirus B19; Pregnancy outcome

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; ERYTHEMA INFECTIOSUM; FEMALE; FETUS; FETUS BLOOD; HUMAN; HYDROPS; INTRAUTERINE BLOOD TRANSFUSION; PARVOVIRUS; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SEROCONVERSION; TERTIARY HEALTH CARE; THROMBOCYTOPENIA;

ALPHA-FETOPROTEINS; ANEMIA; BIOLOGICAL MARKERS; BLOOD TRANSFUSION, INTRAUTERINE; FEMALE; FETAL DEATH; GESTATIONAL AGE; HUMANS; HYDROPS FETALIS; INFANT, NEWBORN; INTESTINES; MIDDLE CEREBRAL ARTERY; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THROMBOCYTOPENIA; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, PRENATAL;

EID: 70349751763     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000236149     Document Type: Article

References (21)

1. Porter HJ, Quantril AM, Fleming KA: B19 parvovirus infection of myocardial cells. Lancet 1998;i:535-536.
2. Morey AL, Keeling JW, Porter HJ, Flemming KA: Clinical and histopathological features of parvovirus B19 infection in the human fetus. Br J Obstet Gynaecol 1992;99:566-574.
3. Public Health Laboratory Service Working Party on Fifth Disease: Prospective study of human parvovirus (B19) infection in pregnancy. BMJ 1990;300:1166-1170.
4. Miller E, Fairley CK, Cohen BJ, Seng C: Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 1998;105:174-178. (Pubitemid 28096296)
5. Soothill PW: Fetal blood sampling before labor; in James DK, Steer PJ, Weiner CP, Gonik B (eds): High Risk Pregnancy, Management Options. London, Saunders, 1999, pp 225-233.
6. Vyas S, Nicolaides KH, Campbell S: Doppler examination of the middle cerebral artery in anemic fetuses. Am J Obstet Gynecol 1990;162:1066-1068. (Pubitemid 20155434)
7. Mari G, Adrignolo A, Abuohamad AZ, et al: The diagnosis of fetal anaemia with Doppler ultrasound in the pregnancy complicated by rhesus-isoimmunization. Ultrasound Obstet Gynecol 1995;5:400-405.
8. Mari G, for the Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses: Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunisation. N Engl J Med 2000;342:9-14.
9. Cosmi E, Mari G, Chiaie L, et al: Noninvasive diagnosis by Doppler ultrasonography of fetal anemia resulting from parvovirus infection. Am J Obstet Gynecol 2002;187:1290-1293. (Pubitemid 35397477)
10. Maxwell DJ, Johnson P, Hurley, Neales K, Allan L, Knott P: Fetal blood sampling and pregnancy related loss in relation to indication. Br J Obstet Gynecol 1991;98:892-897.
11. Bartha JL, Illanes S, Abdel-Fattah SA, Harrison G, Soothill PW: Maternal serum alphafetoprotein, fetal middle cerebral artery blood flow velocity and fetal haemoglobin in pregnancies at risk of fetal anaemia. Prenatal Diagnosis 2006;26:101-104. (Pubitemid 43287090)
12. Yaron Y, Hassan S, Geva E, Kupferminc MJ, Yavetz H, Evans MI: Evaluation of fetal echogenic bowel in the second trimester. Fetal Diagn Ther 1999;14:176-180. (Pubitemid 29276638)
13. Soothill P: Intrauterine blood transfusion for non-immune hydrops fetalis due to parvovirus B19 infection. Lancet 1990;336:121-122. (Pubitemid 20222851)
14. Howe DT, Michailidis GD: The use of intraperitoneal transfusion for the management of severe rhesus iso-immunisation before 20 weeks. J Obstet Gynaecol 2007;27(suppl 1):S45.
15. Nicolaides KH: Normal values. Fetal blood analysis; fetal blood haemoglobin concentration; in Chervenak FA, Isaacson GC, Campbell S (eds): Ultrasound in Obstetrics and Gynecology. Boston, Little, Brown, 1993, pp 1787-1797.
16. Stata Statistical Software [program]: Release 8.0 version. College Station, Stata Corporation, 2003.
17. Schild RL, Bald R, Plath H, Eis-Hübinger AM, Enders G, Hansmann M: Intrauterine management of fetal parvovirus B19 infection. Ultrasound Obstet Gynecol 1999;13:161-166. (Pubitemid 29176888)
18. Enders M, Weidner A, Zoellner I, Searle K, Enders G: Fetal Morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diag 2004;24:513-518. (Pubitemid 39061905)
19. Forestier F, Tissot JD, Vial Y, Daffos F, Hohlfeld P: Haematological parameters of parvovirus B19 infection in 13 fetuses with hydrops fetalis. Br J Haematol 1999;104:925-927. (Pubitemid 29143519)
20. Segata M, Chaoui R, Khalek N, Bahado-Singh R, Paidas MJ, Mari G: Fetal thrombocytopenia secondary to parvovirus infection. Am J Obstet Gynecol 2007;196:61-64. (Pubitemid 46107381)
21. de Haan TR, van den Akker ESA, Porcelijn L, Oepkes D, Kroes ACM, Walther FJ: Thrombocytopenia in hydropic fetuses with parvovirus B19 infection: incidence, treatment and correlation with fetal B19 viral load. BJOG 2008;115:76-81. (Pubitemid 350209614)